Altimmune commences enrolment in Phase II trial of obesity treatment
The relative change from baseline in body weight at 48 weeks following pemvidutide treatment is the trial’s primary endpoint.
Gastrointestinal
Latest in
Gastrointestinal
Pipeline Moves: Arog Pharma terminates early-phase cancer trial, progress prospects tumble
Mesoblast in ulcerative colitis and Sage in major depressive disorder are also reviewed by Clinical Trials Arena.
By
Iterative Scopes and Pfizer enter AI-driven agreement to support IBD trials
Under the agreement, Iterative Scopes will gain access to an IBD clinical trial database of Pfizer.
Pipeline Moves: CuraSen’s Parkinson’s disease and MCI asset’s advancement prospects change with Phase I updates
Rivus and Madrigal’s respective nonalcoholic steatohepatitis assets are also reviewed by Clinical Trials Arena.
By
Pipeline Moves: Roche Phase I suspension plummets further study chances in blood cancers
Celularity in glioblastoma multiforme and Sino Biopharm in gastric cancer are also reviewed by Clinical Trials Arena.
By
Pipeline Moves: J&J ends ulcerative colitis trial, further study chances drop
Clinical Trials Arena reviews a total of six trials, including ones in gram-negative bacterial infections, hepatitis B, and obesity.
By
Regulatory roundup: Albireo ASBT inhibitor shot at further study rises in liver diseases
Roche in ulcerative colitis and Alzamend Neuro in dementia associated with Alzheimer’s disease are also reviewed by GlobalData’s Investigative News…
By
InDex enrols first subject in trial of cobitolimod for ulcerative colitis
The trial will enrol six subjects to assess the systemic uptake of the drug to treat colonic inflammation.